ELVN Enliven Therapeutics, Inc.
Nasdaq · SEC CIK 1672619 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $76.73M 38 sales by 9 insiders
- Filings on record
- 300 since 2021-07-01, latest 2026-09-21 17:23
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% | — | $51.68M |
| Derynck Mika K | Dir | — | $9.56M |
| Collins Helen Louise | Chief MEDICAL Off | — | $5.39M |
| Lyssikatos Joseph P | CSO | — | $4.88M |
| Patel Anish | COO | — | $1.74M |
| Hohl Benjamin | CFO | — | $1.60M |
| Kunkel Lori Anne | Dir | — | $850.3K |
| Kintz Samuel | Pres AND CEO, Dir | — | $613.6K |
| Heyman Richard A. | Dir | — | $413.4K |
Transactions 332
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-01-05 | 2023-01-03 | ELVN | RA CAPITAL MANAGEMENT, L.P. | 10% | P - Purchase | $4.00 | +629.3K | 3.88M | +19% | +$2.52M |
| I | 2023-01-04 | 2023-01-04 | ELVN | Leonard Braden Michael | 10% | S - Sale | $4.00 | -1.25M | 1.77M | -41% | -$5.00M |
| 2022-12-30 | 2022-12-30 | ELVN | Leonard Braden Michael | 10% | S - Sale | $4.04 | -20.0K | 230.0K | -8% | -$80.8K | |
| M | 2022-12-29 | 2022-12-28+ | ELVN | Leonard Braden Michael | 10% | S - Sale | $4.04 | -20.0K | 269.8K | -7% | -$80.8K |
| M | 2022-12-27 | 2022-12-22+ | ELVN | Leonard Braden Michael | 10% | S - Sale | $4.06 | -50.0K | 318.9K | -14% | -$203.0K |
| MI | 2022-12-12 | 2022-12-08+ | ELVN | Shah Rajeev M. | 10% | P - Purchase | $3.87 | +29.9K | 3.25M | +0.9% | +$115.6K |
| MI | 2022-10-24 | 2022-10-20+ | ELVN | Shah Rajeev M. | 10% | P - Purchase | $3.92 | +85.9K | 3.15M | +3% | +$336.8K |
| MI | 2022-10-19 | 2022-10-17+ | ELVN | Kolchinsky Peter | 10% | P - Purchase | $3.68 | +506.2K | 2.77M | +22% | +$1.86M |
| I | 2022-06-21 | 2022-06-16 | ELVN | Leonard Braden Michael | 10% | P - Purchase | $1.11 | +83.2K | 3.02M | +3% | +$92.4K |
| MI | 2022-06-07 | 2022-06-03+ | ELVN | Leonard Braden Michael | 10% | P - Purchase | $1.14 | +33.4K | 2.93M | +1% | +$38.2K |
| MI | 2022-05-18 | 2022-05-16+ | ELVN | Leonard Braden Michael | 10% | P - Purchase | $1.23 | +41.1K | 2.90M | +1% | +$50.5K |
| MI | 2022-04-25 | 2022-04-21+ | ELVN | Leonard Braden Michael | 10% | P - Purchase | $1.40 | +560.0K | 2.85M | +24% | +$783.8K |
| M | 2022-04-07 | 2022-04-05+ | ELVN | KERINS PATRICK J | 10% | S - Sale | $1.08 | -694.6K | 2.87M | -20% | -$750.8K |
| M | 2022-02-23 | 2022-02-18+ | ELVN | MOTT DAVID M | Dir | P - Purchase | $1.45 | +151.5K | 194.0K | +356% | +$219.7K |
| M | 2022-02-17 | 2022-02-15+ | ELVN | MOTT DAVID M | Dir | P - Purchase | $1.19 | +45.9K | 63.2K | +267% | +$54.7K |
| M | 2022-02-14 | 2022-02-10+ | ELVN | MOTT DAVID M | Dir | P - Purchase | $1.23 | +31.8K | 31.8K | New | +$39.2K |
| D | 2022-02-01 | 2022-01-28 | ELVN | Attie Kenneth | SVP, CMO | A - Grant | $0.00 | +34.1K | 34.1K | New | $0 |
| D | 2022-02-01 | 2022-01-28 | ELVN | GRAY MICHAEL | CFO, COO | A - Grant | $0.00 | +39.4K | 42.3K | +1,328% | $0 |
| D | 2022-02-01 | 2022-01-28 | ELVN | Ballal Rahul D. | CEO | A - Grant | $0.00 | +131.4K | 137.0K | +2,343% | $0 |
| M | 2022-01-25 | 2022-01-21+ | ELVN | New Enterprise Associates 14, L.P. | 10% | S - Sale | $1.50 | -134.6K | 3.41M | -4% | -$201.7K |
| M | 2022-01-20 | 2022-01-18+ | ELVN | KERINS PATRICK J | 10% | S - Sale | $1.84 | -26.6K | 3.46M | -0.8% | -$48.7K |
| M | 2022-01-14 | 2022-01-12+ | ELVN | Sonsini Peter W. | 10% | S - Sale | $1.94 | -21.6K | 3.47M | -0.6% | -$41.8K |
| M | 2022-01-11 | 2022-01-07+ | ELVN | NEA Partners 14, L.P. | 10% | S - Sale | $2.07 | -18.8K | 3.49M | -0.5% | -$38.8K |
| M | 2022-01-06 | 2022-01-04+ | ELVN | BASKETT FOREST | 10% | S - Sale | $2.26 | -31.9K | 3.52M | -0.9% | -$72.1K |
| M | 2022-01-03 | 2021-12-30+ | ELVN | SANDELL SCOTT D | 10% | S - Sale | $2.29 | -116.5K | 3.63M | -3% | -$267.0K |
| M | 2021-12-29 | 2021-12-27+ | ELVN | BASKETT FOREST | 10% | S - Sale | $2.36 | -67.4K | 3.70M | -2% | -$159.4K |
| M | 2021-12-27 | 2021-12-09+ | ELVN | Sonsini Peter W. | 10% | S - Sale | $2.36 | -291.2K | 3.72M | -7% | -$688.2K |
| I | 2021-07-28 | 2021-07-16 | ELVN | Chin Mark | Dir | P - Purchase | $6.00 | +1.33M | 2.34M | +132% | +$8.00M |
| AI | 2021-07-23 | 2021-07-16 | ELVN | OrbiMed Capital GP VII LLC | Dir, 10% | P - Purchase | $6.00 | +1.67M | 4.20M | +66% | +$10.00M |
| AI | 2021-07-23 | 2021-07-16 | ELVN | Bonita David P | Dir, 10% | P - Purchase | $6.00 | +1.67M | 4.20M | +66% | +$10.00M |
| I | 2021-07-16 | 2021-07-16 | ELVN | Bonita David P | Dir, 10% | P - Purchase | $6.00 | +1.67M | 1.67M | New | +$10.00M |
| I | 2021-07-16 | 2021-07-16 | ELVN | OrbiMed Capital GP VII LLC | Dir, 10% | P - Purchase | $6.00 | +1.67M | 1.67M | New | +$10.00M |
Purchase Sale Sale after option exercise All abbreviations